Latest News

The clinical-stage biotech could see its shares plummet should there be any clinical setback.

Another profitable year is in the books for investors. Whether you invested in 2025 or are looking to get started, this episode is for

Last August and September, Opendoor Technologies (NASDAQ: OPEN) was one of the hottest meme stocks around. Today, while shares in the real estate iBuyer

Oklo is designing and developing small nuclear reactors. After a strong run in 2025, the company’s stock looks expensive. Long-term investors who understand the

After rising almost 1,000%, the pre-revenue stock looks risky to buy right now.

“Healthy economic and revenue growth, continued profit strength among the largest US stocks, and an emerging productivity boost from AI adoption should lift S&P

Several money experts have sounded the alarm, warning that today’s economy isn’t as strong as some headlines suggest.

With the first full trading week of 2026 now in the books, investors might be wondering if the strong early start in the S&P

Quick Read Oracle stock fell over 40% since September despite strong RPO numbers as investors doubt OpenAI’s ability to pay bills. Oracle maintains commitment

Lucid is burning through boatloads of money, and profitability remains far from sight. That said, there are three important tailwinds the company could enjoy